Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Epizyme Inc (NQ: EPZM ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 11, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Epizyme Inc < Previous 1 2 3 4 5 Next > Epizyme Raises $85M Via Equity Issued At 21% Discount January 27, 2022 Epizyme Inc (NASDAQ: EPZM) has priced its underwritten public offering of 56.7 million shares at Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 27, 2022 Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday January 27, 2022 Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday! Via InvestorPlace 26 Stocks Moving in Thursday's Pre-Market Session January 27, 2022 Gainers The National Security Group, Inc. (NASDAQ: NSEC) rose 63.7% to $15.10 in pre-market trading after VR Insurance Holdings announced acquisition of The National... Via Benzinga Epizyme Announces Pricing of Public Offering of Common Stock January 27, 2022 From Epizyme, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session January 26, 2022 Gainers Reneo Pharmaceuticals (NASDAQ:RPHM Via Benzinga Epizyme Announces Proposed Public Offering of Common Stock January 26, 2022 From Epizyme, Inc. Via Business Wire Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates January 10, 2022 From Epizyme, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Wednesday January 05, 2022 Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... Via Benzinga Epizyme Presents Updates from SYMPHONY-1 Tazemetostat + R2 Combination Study in Relapsed/Refractory Follicular Lymphoma at the 2021 ASH Annual Meeting December 12, 2021 From Epizyme, Inc. Via Business Wire Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual Meeting December 11, 2021 From Epizyme, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session December 10, 2021 Gainers Quoin Pharmaceuticals (NASDAQ: Via Benzinga The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More December 06, 2021 The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... Via Benzinga Exposures Product Safety Epizyme to Present New Data from Its Oncology Portfolio at 2021 American Society of Hematology Annual Meeting December 02, 2021 From Epizyme, Inc. Via Business Wire Epizyme Announces Updates to Its Board of Directors November 18, 2021 From Epizyme, Inc. Via Business Wire Epizyme to Participate in Jefferies London Healthcare Conference November 12, 2021 From Epizyme, Inc. Via Business Wire Epizyme's Return On Capital Employed Insights November 10, 2021 Benzinga Pro data, Epizyme (NASDAQ:EPZM) reported Q3 sales of $5.20 million. Earnings fell to a loss of $64.16 million, resulting in a 10.09% decrease from last quarter. In Q2,... Via Benzinga Epizyme, inc (EPZM) Q3 2021 Earnings Call Transcript November 09, 2021 EPZM earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update November 09, 2021 From Epizyme, Inc. Via Business Wire The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... Via Benzinga Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 05, 2021 From Epizyme, Inc. Via Business Wire The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More November 08, 2021 Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... Via Benzinga Epizyme Receives Fast Track Designation from U.S. FDA and Announces Initiation of Phase 1/1b Study of its Novel SETD2 Inhibitor, EZM0414 November 04, 2021 From Epizyme, Inc. Via Business Wire The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 Epizyme Announces Date of Third Quarter 2021 Financial Results November 02, 2021 From Epizyme, Inc. Via Business Wire Epizyme Launches In My Blood Online Resource to Empower People Living with Follicular Lymphoma to Play a Proactive Role in Treatment-Decision Making November 01, 2021 From Epizyme, Inc. Via Business Wire Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 07, 2021 From Epizyme, Inc. Via Business Wire Epizyme Announces Data from TAZVERIK® (Tazemetostat) Clinical Programs to be Presented During Poster Sessions at 2021 ESMO Virtual Congress September 14, 2021 From Epizyme, Inc. Via Business Wire Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 20, 2021 From Epizyme, Inc. Via Business Wire The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.